Samsung Heavy Industries secured a $351 million order for two container ships from an African client, bringing its 2026 order total to $1.2 billion, or 9% of its annual target.
#YonhapInfomax #SamsungHeavyIndustries #ContainerShips #OrderIntake #EcoFriendlyTechnology #4686BillionWon #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=104983
Samsung Heavy Industries reported 2025 revenue of 10.65 trillion won and operating profit of 862.2 billion won, both exceeding multi-year highs and matching market expectations, driven by high-margin orders and offshore project growth.
#YonhapInfomax #SamsungHeavyIndustries #OperatingProfit #Revenue #FLNGProjects #OrderIntake #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103101
Samsung Heavy Industries Posts 10.65 Trillion Won in 2025 Revenue, Operating Profit Surges 71.5% to 862.2 Billion Won—In Line With Expectations (Comprehensive)

Samsung Heavy Industries reported 2025 revenue of 10.65 trillion won and operating profit of 862.2 billion won, both exceeding multi-year highs and matching market expectations, driven by high-margin orders and offshore project growth.

Yonhap Infomax
Daebo Engineering & Construction Co. achieved record-high annual orders of 2.1 trillion won ($1.6 billion) for the second year in a row, driven by major public and private sector projects.
#YonhapInfomax #DaeboEngineeringConstruction #OrderIntake #RecordHigh #GTXLineB #PublicPrivatePartnerships #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97500
Daebo Engineering & Construction Surpasses 2 Trillion Won in Orders—Records All-Time High for Second Consecutive Year

Daebo Engineering & Construction Co. achieved record-high annual orders of 2.1 trillion won ($1.6 billion) for the second year in a row, driven by major public and private sector projects.

Yonhap Infomax
Samsung Biologics Co. secures a $1.3 billion CMO contract with a US pharmaceutical firm, pushing its 2025 order intake past 5 trillion won and reinforcing its global leadership in biomanufacturing capacity.
#YonhapInfomax #SamsungBiologics #CMOContract #OrderIntake #Biomanufacturing #USPharmaceuticalCompany #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=80780
Samsung Biologics Signs $1.3 Billion CMO Deal With US Pharma Firm, Annual Orders Surpass 5 Trillion Won

Samsung Biologics Co. secures a $1.3 billion CMO contract with a US pharmaceutical firm, pushing its 2025 order intake past 5 trillion won and reinforcing its global leadership in biomanufacturing capacity.

Yonhap Infomax
Daebo Engineering & Construction is ramping up experienced hiring in civil engineering and safety, bucking industry downsizing trends, after surpassing 1 trillion won in orders this year with major infrastructure and private investment projects.
#YonhapInfomax #DaeboEngineeringConstruction #OrderIntake #GTXBLine #PrivateInvestmentProject #RecruitmentDrive #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=75772
Daebo Engineering & Construction Launches Large-Scale Experienced Hiring Amid Robust Order Growth

Daebo Engineering & Construction is ramping up experienced hiring in civil engineering and safety, bucking industry downsizing trends, after surpassing 1 trillion won in orders this year with major infrastructure and private investment projects.

Yonhap Infomax
Samsung Biologics Co. has secured 440.5 billion won ($322 million) in new CDMO contracts, pushing its 2025 order intake past 3 trillion won and accelerating global expansion.
#YonhapInfomax #SamsungBiologics #CDMOContracts #OrderIntake #Biopharmaceuticals #CapacityExpansion #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64561
Samsung Biologics Secures 440.5 Billion Won CDMO Contracts—Annual Orders Surpass 3 Trillion Won (Comprehensive)

Samsung Biologics Co. has secured 440.5 billion won ($322 million) in new CDMO contracts, pushing its 2025 order intake past 3 trillion won and accelerating global expansion.

Yonhap Infomax